FindTrial
Sign In

Treatment retention among women substance users

Retention and associated factors among women seeking treatment for drug dependence - a longitudinal study - RAW

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/068975
Enrollment
30
Registered
2024-06-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F10-F19- Mental and behavioral disorders due to psychoactive substance use

Interventions

Intervention1: NIL: NIL

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult female (age > 18 years) Newly registered at Women clinic (within 1st week) Dependence on any substance (according to ICD-10) except those who are dependent on tobacco only

Exclusion criteria

Exclusion criteria: Inability to participate in the interview due to any medical / psychiatric condition or intoxication

Design outcomes

Primary

MeasureTime frame
To determine the retention rate of attendees of women clinic at 4, 12 and 24 weeks after initiation of treatmentTimepoint: At 4, 12 and 24 weeks after initiation of treatment—

Secondary

MeasureTime frame
To determine the patient and treatment related factors associated with retention at 4, 12 and 24 weeks after initiation of treatment To assess the changes in the other outcome variables (addiction profile, withdrawal, craving and treatment perception) at 4, 12 and 24 weeks after initiation of treatmentTimepoint: At 4, 12 and 24 weeks after initiation of treatment—

Countries

India

Contacts

Public ContactDinesh M

All India Institute of Medical Sciences, New Delhi

piyum2008@gmail.com9625082808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026